摘要
目的探讨巴曲酶和低分子肝素(LMWH)治疗急性脑梗死的疗效.方法连续积累2002-01～2004-03广东佛山市顺德桂洲医院150例急性脑梗死住院患者,随机分为巴曲酶组(42例)、低分子肝素组(48例)和对照组(60例),均在发病后6～72 h内给药,治疗前后对神经功能缺损程度进行评价,比较巴曲酶与低分子肝素治疗急性脑梗死的疗效.结果巴曲酶组治愈率显著高于低分子肝素组(P<0.05),治疗后巴曲酶组患者的神经功能缺损程度的恢复也显著优于低分子肝素组(P<0.05).结论巴曲酶治疗急性脑梗死疗效优于低分子肝素.
Objective The paper objectively analyses the Batroxobin and LMWH therapeutic effects on acute cerebral infarction. Methods 150 cases suffering from acute cerebral infarction were selected, who were hospitalized from Jan, 2002 to Mar. 2004, The Batroxobin group was composed of 42 cases; the LMWH group consisted of 48 cases and control group 60 case. All of the 150 cases were given drugs during 6～72 hours in hospital. The patients＇ neurologic functional deficiency were measured before and after the treatment, Results The patients＇ curative rate in Batroxobin group was significantly higher than that in LMWH group （ P 〈 0.05）, And the patients＇ neurologic functional deficiency of the hatroxobin group improved significantly after treatment （ P 〈0.05）, Conclusion The effects of hatroxohin on acute cerebral infarction is better than that of LMWH.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2005年第8期715-717,共3页
Chinese Journal of Practical Internal Medicine
关键词
脑梗死
降纤
抗凝
Cerebral infarction Defibrination Anticoagulation
